Northwestern Mutual Wealth Management
CTIC

Northwestern Mutual Wealth Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-46
Closed – – 2807
2018
Q4 		$0 Buy
+46
New +$76 ﹤0.01% 2802
2017
Q2 		– Sell
-100
Closed – – 2285
2017
Q1 		$0 Buy
+100
New +$462 ﹤0.01% 2668

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Northwestern Mutual Wealth Management's CTIC Position: Q1 2019 in Review

Northwestern Mutual Wealth Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2019, closing a stake of 46 shares.

Northwestern Mutual Wealth Management first reported a position in CTIC in Q1 2017 and held it in 2 quarters. The position peaked at $0 in Q4 2018. 67 funds tracked by Wall St. Rank hold CTIC as of Q1 2019.

  • Northwestern Mutual Wealth Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q1 2019 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 46 CTI BioPharma Corp. (DE) Common Stock shares in Q1 2019.
  • Northwestern Mutual Wealth Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2017 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $0 in Q4 2018.
  • 67 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2019.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2019, filed 10 May 2019.